Impact of low frequency pulsed magnetic fields on pain intensity, quality of life and sleep disturbances in patients with painful diabetic polyneuropathy

Diabetes and Metabolism

Volumn 34, Issue 4, 2008, Pages 349-354

  Wrobel M P ^a   Szymborska Kajanek, A ^a   Wystrychowski, G ^a   Biniszkiewicz, T ^a   Sieron Stoltny K ^a   Sieron A ^a   Pierzchala K ^a   Grzeszczak, W ^a   Strojek, K ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Diabetes mellitus; Low frequency magnetic fields; Painful diabetic polyneuropathy; Treatment

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DIABETIC NEUROPATHY; GLYCEMIC CONTROL; HUMAN; MAGNETIC FIELD; MAJOR CLINICAL STUDY; NOCICEPTION; PAIN; PAIN ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; SHAM PROCEDURE; SLEEP DISORDER; VISUAL ANALOG SCALE;

ADULT; AGED; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; ELECTROMAGNETIC FIELDS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRES; SLEEP DISORDERS;

EID: 51649096343     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.02.003     Document Type: Article

References (39)

1. In: Kahn C.R., King G.L., Moses A.C., Weir G.C., Jacobson A.M., and Smith R.J. (Eds). Joslin's diabetes mellitus. 14th ed. (2005), Lippincott Wiliams & Wilkins, Philadelphia
2. Vinik A.I., Park T.S., Stansberry K.B., and Pittenger G.L. Diabetic neuropathies. Diabetologia 43 (2000) 957-973
3. Nordin M., Nyström B., Wallin U., and Hagbarth K.E. Ectopic sensory discharges and paresthesiae in patients with disorders of peripheral nerves, dorsal roots and dorsal columns. Pain 20 (1984) 231-245
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-822
5. Sindrup S.H., and Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83 (1999) 389-400
6. Dooley D.J., Meder W.P., Suman-Chauhan N., Duffy S., Clussman H., and Gothert M. Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42 (2002) 229-236
7. Kumar D., Alvaro M.S., Julka I.S., and Marshall H.J. Diabetic peripheral neuropathy. Effectiveness of electrotherapy and amitriptyline for symptomatic relief. Diabetes Care 21 (1998) 1322-1325
8. Ametov A.S., Barinov A., Dyck P.J., Hermann R., Kozlova N., and Litchy W.J. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 26 (2003) 770-776
9. Abuaisha B.B., Costanzi J.B., and Boulton A.J. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract 39 (1998) 115-121
10. Zinman L.H., Ngo M., Ng E.T., Nwe K.T., Gogov S., and Bril V. Low-intensity laser therapy for painful symptoms of diabetic sensorimotor polyneuropathy: a controlled trial. Diabetes Care 27 (2004) 921-924
11. Weintraub M.I., Wolfe G.I., Barohn R.A., Cole S.P., Parry G.J., Hayat G., et al. Magnetic Research Group. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehabil 84 (2003) 736-746
12. Weintraub M.I., and Cole S.P. Pulsed magnetic field therapy in refractory neuropathic pain secondary to peripheral neuropathy: electrodiagnostic parameters-pilot study. Neurorehabil Neural Repair 18 (2004) 42-46
13. Musaev A.V., Guseinova S.G., and Imamverdieva S.S. The use of pulsed electromagnetic fields with complex modulation in the treatment of patients with diabetic polyneuropathy. Neurosci Behav Physiol 33 (2003) 745-752
14. Banaszkiewicz W., and Straburzyński G. Influence of pulsed magnetic fields on selected parameters of metabolic control and acid: alkaline balance. Baln Pol 34 (1992) 109-119
15. Boulton A.J.M., Vinik A.I., Arezzo J.C., Bril V., Feldman E.L., and Freeman R. Diabetic Neuropathies. A statement by the American Diabetes Association. Diabetes Care 28 (2005) 956-962
16. Melzack R. The Short-Form McGill pain questionnaire. Pain 30 (1987) 191-197
17. http://www.vioforjps.pl/_index.html.
18. www.euroqol.org.
19. Hays R.D., and Stewart A.L. Sleep measures. In: Stewart A.L., and Ware J.E. (Eds). Measuring functioning and well-being: The medical outcomes study approach (1992), Duke University Press, Durham, NC
20. Spritzer KL, Hays R. http://gim.med.ucla.edu/FacultyPages/Hays/surveys.htmD. MOS Sleep Scale. A manual for use and scoring, version 1.0, 2003.
21. Kolia G., Milojevic J.P., Cantineau R., Ruiz B., Coudert S., and Bataille. Can severe acute pain escape visual analog scale screening in the ED?. Am J Emerg Med 22 (2004) 238-241
22. Freynhagen R., Strojek K., Whalen E., Balkenohl M., Griesing T., et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115 (2005) 254-263
23. Supranowicz P. Assessment of usefulness of visual analog scale (VAS) for measurements of attitude of the youth in health aspect. Przegl Epidemiol 57 (2003) 541-551
24. Cieślar G., Sieroń A., and Radelli J. Assesment of pulsed magnetic field action in patients with painful diabetic neuropathy including vibration perception. Baln Pol (1995) 37
25. Sadurska K., Łukomska E., Szwedek R., and Wierusz-Wysocka B. Evaluation of efficacy of pulsed magnetic fields in treatment of diabetic neuropathy and angiopathy. Baln Pol 34 (1992) 109-119
26. Wörz M. Pharmacology of pain (1992), PZWL, Warszawa
27. In: Hausman-Petrusewicz I. (Ed). Clinical electromyography (1986), PZWL, Warszawa [wyd II]
28. Feldman E.L., Stevens M.J., Thomas P.K., Brown M.B., Canal N., and Greene D.A. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17 (1994) 1281-1289
29. Claus D., Mustafa C., Vogel W., Herz M., and Neundörfer B. Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function. Muscle Nerve 16 (1993) 757
30. Karasek M., Czernicki J., Woldańska-Okońska M., Żylińska K., and Świe{ogonek}tosławski J. Chronic exposure 25-80 μT, 200 Hz magnetic fields does not influence serum melatonin concentrations in patients with low back pain. J Pineal Res 29 (2000) 81-85
31. Mantovani M., Kaster M.P., Pertile R., Calixto J.B., Rodrigues A.L., and Santos A.R. Mechanisms involved in the antinociception caused by melatonin in mice. J Pineal Res 41 (2006) 382-389
32. Ulugol A., Dokmeci D., Guray G., Sapolyo N., Ozyigit F., and Tamer M. Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: Possible involvements of the l-arginine-NO pathway and opioid system. Life Sci 78 (2006) 1592-1597
33. Laitl-Kobierska A., Cieślar G., Sieroń A., and Grzybek H. Influence of alternating extremely low frequency ELF magnetic field on structure and function of pancreas in rats. Bioelectromagnetics 23 (2002) 49-58
34. 3H glucose absorption in brain and selected tissues of rats including role of NO. Praca doktorska, Śla{ogonek}ska Akademia Medyczna 2003.
35. Wróbel M., Szymborska-Kajanek A., Karasek D., Biniszkiewicz T., Sieroń-Słotny K., Grzeszczak W., et al. Influence of alternating low frequency magnetic fields in patients with diabetic polyneuropathy: pilot study. Diabetologia Doświadczalna i Kliniczna 5 (2005) 59-63
36. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;29:977-86.
37. UK Prospective Diabetes Study (UKPDS) Group intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
38. Blackman C., Benane S., Kinney L., Joines W.T., and House D.E. Effects of ELF fields on calcium-ion efflux from brain tissue in vitro. Radiat Res 92 (1982) 510-520
39. Halle B. On the cyclotron resonance mechanism for magnetic field effects on transmembrane ion conductivity. Bioelectromagnetics 9 (1988) 381-385